Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Catton

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Neuro-Oncology Advances|May 19, 2025
Survival outcomes and clinical characteristics of brain metastases from prostate cancer: A single-center analysisKurl Jamora, Adeodatus Vito Nicanor, Ayah Erjan, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2018
Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centresDario Callegaro, Rosalba Miceli, Sylvie Bonvalot, et al.
International Journal of Radiation Oncology, Biology, Physics|August 28, 2022
Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate CancerRachel M Glicksman, Matthew Ramotar, Ur Metser, et al.
International Journal of Radiation Oncology, Biology, Physics|November 25, 2025
Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical TrialRachel M Glicksman, Jeff Winter, Andrew McPartlin, et al.
European Urology|March 9, 2021
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis HypothesisRachel M Glicksman, Ur Metser, Douglass Vines, et al.
Eclinicalmedicine|January 1, 2020
Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivorsDario Callegaro, Rosalba Miceli, Sylvie Bonvalot, et al.
The Lancet. Oncology|May 15, 2023
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysisAlexandre R Zlotta, Leslie K Ballas, Andrzej Niemierko, et al.
Lancet (London, England)|October 1, 2020
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trialChristopher C Parker, Noel W Clarke, Adrian D Cook, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Neuro-Oncology Advances|May 19, 2025
Survival outcomes and clinical characteristics of brain metastases from prostate cancer: A single-center analysisKurl Jamora, Adeodatus Vito Nicanor, Ayah Erjan, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2018
Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centresDario Callegaro, Rosalba Miceli, Sylvie Bonvalot, et al.
International Journal of Radiation Oncology, Biology, Physics|August 28, 2022
Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate CancerRachel M Glicksman, Matthew Ramotar, Ur Metser, et al.
International Journal of Radiation Oncology, Biology, Physics|November 25, 2025
Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical TrialRachel M Glicksman, Jeff Winter, Andrew McPartlin, et al.
European Urology|March 9, 2021
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis HypothesisRachel M Glicksman, Ur Metser, Douglass Vines, et al.
Eclinicalmedicine|January 1, 2020
Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivorsDario Callegaro, Rosalba Miceli, Sylvie Bonvalot, et al.
The Lancet. Oncology|May 15, 2023
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysisAlexandre R Zlotta, Leslie K Ballas, Andrzej Niemierko, et al.
Lancet (London, England)|October 1, 2020
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trialChristopher C Parker, Noel W Clarke, Adrian D Cook, et al.
Pageof 14